Emerging therapeutic opportunities for integrin inhibitors

RJ Slack, SJF Macdonald, JA Roper… - Nature Reviews Drug …, 2022 - nature.com
Integrins are cell adhesion and signalling proteins crucial to a wide range of biological
functions. Effective marketed treatments have successfully targeted integrins αIIbβ3 …

[HTML][HTML] Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease

F Åberg, CD Byrne, CJ Pirola, V Männistö… - Journal of …, 2023 - Elsevier
Alcohol use and metabolic syndrome are highly prevalent in the population and frequently
co-exist. Both are implicated in a large range of health problems, including chronic liver …

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update

A Berzigotti, E Tsochatzis, J Boursier, L Castera… - Journal of …, 2021 - Elsevier
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

[PDF][PDF] Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases

P Ginès, L Castera, F Lammert, I Graupera… - …, 2022 - Wiley Online Library
Cirrhosis, highly prevalent worldwide, develops after years of hepatic inflammation
triggering progressive fibrosis. Currently, the main etiologies of cirrhosis are non‐alcoholic …

Geographical similarity and differences in the burden and genetic predisposition of NAFLD

TCF Yip, E Vilar‐Gomez, S Petta, Y Yilmaz… - Hepatology, 2023 - journals.lww.com
NAFLD has become a major public health problem for more than 2 decades with a growing
prevalence in parallel with the epidemic of obesity and type 2 diabetes (T2D). The disease …

Cigarette smoking and liver diseases

D Marti-Aguado, A Clemente-Sanchez, R Bataller - Journal of hepatology, 2022 - Elsevier
Cigarette smoking is a preventable risk factor for premature morbidity and mortality. A history
of smoking is observed in approximately 40% of patients with liver disease, while a growing …

Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017–2018

X Zhang, NI Heredia, M Balakrishnan, AP Thrift - PloS one, 2021 - journals.plos.org
Background Non-alcoholic fatty liver disease (NAFLD) is increasingly common in the adult
population. In the United States, the overall burden of NAFLD is unknown due to challenges …

Physical activity is associated with nonalcoholic fatty liver disease and significant fibrosis measured by FibroScan

D Kim, P Konyn, G Cholankeril, A Ahmed - Clinical Gastroenterology and …, 2022 - Elsevier
Background and Aims Studies evaluating the association of 2018 Physical Activity
Guidelines for Americans (PA Guidelines) with nonalcoholic fatty liver disease (NAFLD) and …

Recent epidemiology of nonalcoholic fatty liver disease

S Murag, A Ahmed, D Kim - Gut and liver, 2020 - pmc.ncbi.nlm.nih.gov
The ongoing obesity epidemic and the increasing recognition of metabolic syndrome have
contributed to the growing prevalence of nonalcoholic fatty liver disease (NAFLD), the most …

Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)

P Burra, D Bizzaro, A Gonta, S Shalaby… - Liver …, 2021 - Wiley Online Library
NAFLD/NASH is a sex‐dimorphic disease, with a general higher prevalence in men. Women
are at reduced risk of NAFLD compared to men in fertile age, whereas after menopause …